The Latest Headlines at American Banking and Market News
Iridium Communications (NASDAQ:IRDM) Given “Neutral” Rating at BWS Financial
BWS Financial reissued their neutral rating on shares of Iridium Communications (NASDAQ:IRDM – Free Report) in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has a $30.00 target price... More of this article »
LSI Industries (NASDAQ:LYTS) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of LSI Industries (NASDAQ:LYTS – Free Report) in a research report sent to investors on Monday, Benzinga reports. The firm currently has a $20.00 price objective on the construction... More of this article »
Intuit (NASDAQ:INTU) Downgraded by StockNews.com to Hold
StockNews.com downgraded shares of Intuit (NASDAQ:INTU – Free Report) from a buy rating to a hold rating in a report released on Monday morning. Several other research analysts also recently commented on INTU. Wells Fargo &... More of this article »
Lotus Technology (NASDAQ:LOT) Now Covered by Analysts at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft assumed coverage on shares of Lotus Technology (NASDAQ:LOT – Free Report) in a research note published on Monday morning, Benzinga reports. The firm issued a hold rating and a $7.00 price target... More of this article »
LifeStance Health Group (NASDAQ:LFST) Given Overweight Rating at Morgan Stanley
Morgan Stanley reissued their overweight rating on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a research note published on Monday, Benzinga reports. The brokerage currently has a $10.00 target price on... More of this article »
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $90.00 by Analysts at Needham & Company LLC
Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) had its target price lifted by Needham & Company LLC from $82.00 to $90.00 in a report released on Monday, Benzinga reports. They currently have a buy rating on the biopharmaceutical... More of this article »
Krystal Biotech (NASDAQ:KRYS) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report published on Monday, Benzinga reports. The brokerage currently has a $200.00 price objective on the stock. A number... More of this article »
Iradimed’s (IRMD) “Buy” Rating Reaffirmed at Roth Mkm
Roth Mkm reaffirmed their buy rating on shares of Iradimed (NASDAQ:IRMD – Free Report) in a report released on Monday, Benzinga reports. The brokerage currently has a $65.00 price target on the medical equipment provider’s... More of this article »
Meta Platforms (NASDAQ:META) Price Target Lowered to $555.00 at KeyCorp
Meta Platforms (NASDAQ:META – Free Report) had its target price trimmed by KeyCorp from $575.00 to $555.00 in a research note released on Monday morning, Benzinga reports. The firm currently has an overweight rating on the social... More of this article »
LivePerson (NASDAQ:LPSN) Downgraded by StockNews.com to Sell
StockNews.com lowered shares of LivePerson (NASDAQ:LPSN – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday morning. A number of other research firms have also recently commented... More of this article »
Meta Platforms’ (META) “Market Outperform” Rating Reaffirmed at JMP Securities
JMP Securities restated their market outperform rating on shares of Meta Platforms (NASDAQ:META – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The brokerage currently has a $550.00... More of this article »
Independent Bank (NASDAQ:INDB) Given New $60.00 Price Target at Keefe, Bruyette & Woods
Independent Bank (NASDAQ:INDB – Free Report) had its price objective trimmed by Keefe, Bruyette & Woods from $64.00 to $60.00 in a report published on Monday, Benzinga reports. The firm currently has a market perform rating... More of this article »
Karooooo (NASDAQ:KARO) Receives Overweight Rating from Morgan Stanley
Morgan Stanley reaffirmed their overweight rating on shares of Karooooo (NASDAQ:KARO – Free Report) in a research note released on Monday morning, Benzinga reports. Morgan Stanley currently has a $31.00 price objective on the... More of this article »